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Association between high-fat diet 
feeding and male fertility in high 
reproductive performance mice
M. D. Gómez-elías  1,5, T. S. Rainero cáceres1,5, M. M. Giaccagli1, V. A. Guazzone2,3, 
G. n. Dalton4, A. De Siervi4, P. S. cuasnicú1, D. J. cohen1,5* & V. G. Da Ros  1,5
The increasing worldwide prevalence of metabolic syndrome (MetS), especially in younger populations, 
is a risk factor for fertility disorders. However, a direct correlation of MetS with male infertility still 
remains unclear. In this work, we evaluated whether MetS has a negative impact on fertility of hybrid 
male mice with high reproductive performance. To induce a MetS-like condition, (C57BL/6xBALB/c) F1 
male mice were fed a high-fat diet (HFD, 30% fat) for 19 weeks, while controls received a normal-fat diet 
(NFD, 6% fat). HFD-fed animals exhibited increased body weight, hypercholesterolemia, hyperglycemia 
and glucose intolerance. In vivo fertilisation assays performed along the treatment period showed no 
differences in fertilisation nor in vitro embryo development rates between groups. While testicular 
weight and morphology were similar in both groups, HFD-fed mice presented lighter epididymides 
and higher amounts of gonadal fat. Moreover, sperm count was lower in HFD-fed mice, despite normal 
sperm viability, morphology, motility or acrosome reaction. Finally, no differences were observed in in 
vitro fertilisation rates between groups. In summary, although HFD feeding altered some reproductive 
parameters, it did not impair male fertility in high performance breeders suggesting the possibility 
that a fertility impairment could be the result of the cumulative combination of environmental and/or 
genetic factors.
Infertility is a global health problem affecting 10–15% of couples in reproductive age1. While in most of the cases 
its etiology can be attributed to female or male factors, almost 20% of them correspond to idiopathic infertility. In 
particular, the evaluation and classification of male infertility relies on a semen analysis including three param-
eters: concentration, morphology and motility, which have limitations as predictors of sperm fertilising ability2. 
In addition, there is growing evidence supporting that lifestyle factors can affect male fertility through alterations 
in endocrine profiles, spermatogenesis and sperm function3,4. Thus, the identification of the factors contributing 
to infertility may be critical to offer simpler and/or more effective therapeutic options than the general spectrum 
of available treatments.
Metabolic syndrome (MetS) has been defined as a set of physiopathological disorders comprising the increase 
of at least three of the following parameters: abdominal obesity, blood pressure, triglycerides, cholesterol and 
fasting glucose5. In the last 40–50 years, its prevalence has increased in epidemic proportions, affecting 20–25% of 
the general population6. With the increasing number of children, adolescents and young adults dealing with this 
metabolic disorder, the risk to acquire associated diseases may become a serious health problem in the coming 
years7. In particular, the acceleration in the onset of MetS makes it coincident with the reproductive age, being 
able to affect any of the multiple processes involved in reproduction (i.e. hormone production, gametogenesis, 
fertilisation and embryo development), thus compromising the possibility of a couple to achieve pregnancy either 
by direct effects on reproductive organs or cells, or by indirect effects through other systems.
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Given the complex interactions between obesity, dyslipidemia, hyperinsulinemia and the reproductive axis8, 
the effect of MetS as a clinical entity has been less studied than each of its separated components in relation to 
the fertility of the affected individuals. Despite its relevance, the effect of MetS on male reproductive function 
has emerged as a critical topic of study only recently. MetS may affect male fertility through several mecha-
nisms including endocrine system regulation, scrotal temperature elevation, oxidative stress and alteration of 
erectile and ejaculatory functions, which can impair sperm production and/or function9. However, the informa-
tion obtained so far is controversial10–15 probably due to the multifactorial nature of this syndrome in addition 
to the presence of both external (smoking, drugs, stress, etc.) and/or genetic intrinsic susceptibility factors that 
can affect fertility. In addition, the impact of these factors on fertility is uncertain, as most studies only examine 
semen parameters rather than sperm function. Therefore, the development of animal models by chronically feed-
ing them high-fat diets to mimic MetS has resulted in a very useful tool for this type of study7,16. In this sense, 
a recently published systematic meta-analysis of the effect of high-fat diets on sperm traits and/or male fertil-
ity in different animal models has shown an association between obesity and male fertility without evaluating 
other MetS features17. In the case of the mouse model, most of the studies published so far and included in this 
meta-analysis have been performed in C57BL/6 mice which are poor reproducers18. In this regard, it has been 
described that multifactorial traits could be attributable to susceptibility genes modulated by the genetic back-
ground19. Therefore, with the purpose of dissecting the low reproductive ability of that animal model from the 
actual impact of MetS on fertility, we wondered whether the acquisition of a metabolic disorder could affect the 
fertility of males from a mouse strain without preexisting reproductive deficiencies. In view of this, in the present 
study, we evaluated the fertility and sperm functionality of a hybrid mouse strain with high reproductive perfor-
mance fed a high-fat diet as an experimental MetS model.
Results
Generation of a MetS-like condition in B6CF1 male mice. High-fat diet (HFD) fed B6CF1 male mice 
gained more weight than age-matched normal-fat diet (NFD)-fed controls, resulting in a significantly higher 
body weight at week 11 that persists up to week 19 (Fig. 1a). Both total food and fat intakes showed significant 
differences between the control and treated groups: total food intake was higher in the NFD group of animals 
whereas fat intake was higher in the HFD group (Fig. 1b). As a consequence, energy intake was significantly 
higher in HFD-fed males (Fig. 1c). Considering that feed efficiency was similar in both cases (Fig. 1d), these 
results support that body weight gain in HFD-fed animals could be attributed to a higher fat intake.
Figure 1. HFD feeding in B6CF1 male mice. (a) Weekly average body weight of male mice in NFD and HFD 
groups; (b) daily food intake (white bars) and consumed fat (grey bars); (c) daily energy intake (white bars) and 
energy provided by fat (grey bars); (d) feed efficiency (grams of weight gain per energy intake unit). Data are 
expressed as mean ± SEM. nNFD = 9, nHFD = 9. *p < 0.05, **p < 0.01, ***p < 0.001.
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To evaluate the metabolic condition of treated animals, fasting blood glucose was measured at weeks 12 and 18 
of treatment. In both cases, significantly higher values were observed for HFD than NFD group (Fig. 2a). In order 
to obtain additional information regarding the glucose metabolism, glucose tolerance test (GTT) was performed 
at week 18. Contrary to the males belonging to the NFD group, HFD-fed animals showed higher blood glucose 
levels 30 min after glucose injection, and a different subsequent response that did not reach the basal levels at the 
end of the study (Fig. 2b). As a consequence, there was also a significant difference between the area under the 
curve (AUC) of NFD and HFD groups (NFD: (3.6 ± 0.3) × 104 vs HFD: (4.9 ± 0.3) × 104, p < 0.01).
Different metabolic parameters were also determined at the moment of euthanasia. HFD-fed males presented 
significantly higher levels of serum cholesterol than those corresponding to the control group (Fig. 2c), and there 
was no difference between the two groups in either serum triglyceride concentration (Fig. 2d) or liver weight 
(Fig. 2e). Liver histopathological analysis showed that HFD-fed animals did not develop global steatosis although 
some cytoplasmic vacuoles were observed (Fig. 2f). Therefore, the increased body weight, hypercholesterolemia 
and hyperglycemia in HFD-fed animals were consistent with the development of a MetS-like condition.
Effect of a HFD on in vivo fertilisation of B6CF1 male mice. To assess the impact of the HFD on 
the fertility of B6CF1 male mice, in vivo fertilisation studies were carried out at treatment weeks 12, 16 and 18. 
Pre-pubertal superovulated females were used as a way to challenge sperm to a high number of ovulated eggs 
allowing the detection of deficiencies in sperm fertilising ability not evident under regular mating conditions20. 
Mating success, measured as the proportion of females presenting copulatory plug after being caged with a male 
the night of hCG administration, showed no differences between NFD and HFD groups (Table 1). In addition, 
similar in vivo fertilisation rates were observed for both groups at all the evaluated time points (Table 1). In vitro 
development to the blastocyst stage of in vivo fertilised eggs was also recorded, without observing significant 
differences between groups (Table 1).
Effect of a HFD on in vitro sperm analysis of B6CF1 male mice. Sperm from HFD-fed mice were 
subjected to in vitro analysis for evaluation of potential differences that could have been overcome under in vivo 
conditions. Testicular weight was similar in HFD- and NFD-fed animals (Fig. 3a). Therefore, HFD-fed mice 
presented a significant decrease in testicular/body weight ratio compared to controls (NFD: 0.439 ± 0.006% 
vs HFD: 0.37 ± 0.01%, p < 0.001). By contrast, a decreased epididymal weight was observed in HFD animals 
(Fig. 3b) with a consequent significant difference in epididymal/body weight ratio (NFD: 0.174 ± 0.006% vs HFD: 
Figure 2. Effect of HFD consumption on metabolic parameters of B6CF1 male mice. (a) Fasting glucose levels 
were determined at week 12 and 18 (nNFD = 9, nHFD = 9). (b) Glucose tolerance test (GTT) was performed 
in week 18 after i.p glucose administration (2 g/kg body weight) after 6 h of fasting (nNFD = 5, nHFD = 6). (c) 
Serum cholesterol and (d) triglycerides levels were determined after euthanasia (nNFD = 9, nHFD = 9). (e) Mean 
weight of livers from NFD- and HFD-fed male mice (nNFD = 4, nHFD = 3). (f) Representative micrographs of 
Hematoxylin and Eosin stained liver sections from NFD- and HFD-fed male mice. Bar = 50 µm. Data are 
expressed as median with interquartile range for (a,b), and mean ± SEM for (c–e). *p < 0.05, **p < 0.01, 
***p < 0.001.
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0.114 ± 0.008%, p < 0.001). No pathological alterations were found after histological examination of testes and 
epididymides of HFD- and NFD-fed animals (Fig. 3c). In addition, gonadal fat weight was significantly higher in 
HFD-fed mice compared to the control group (Fig. 3d).
Sperm analysis showed significant differences between HFD- and NFD-fed mice in cauda epididymal sperm 
count (Fig. 4a), whereas similar values were observed in both groups for sperm viability (Fig. 4b), morphology 
(Fig. 4c) and progressive motility (Fig. 4d). After in vitro capacitation, sperm from both groups exhibited a com-
parable ability to undergo spontaneous acrosome reaction (Fig. 5a). Finally, in vitro fertilisation (Fig. 5b) and 
early embryo development rates (Fig. 5c) showed no difference between groups. In summary, the functional 
experiments showed that, although presenting lower sperm count, HFD-fed B6CF1 male mice did not exhibit 




In vivo Fertilisation rate (%) In vitro Embryo development rate (%)
week 12 week 16 week 18 week 12 week 16 week 18
NFD 21/23 81.0 ± 6.9 (n = 7)
77.1 ± 7.8 
(n = 7)
67.1 ± 9.9 
(n = 7)
87.2 ± 4.7 
(n = 7)
83.5 ± 3.3 
(n = 7)
85.7 ± 6.5 
(n = 6)
HFD 21/24 73.6 ± 7.1 (n = 6)
76.9 ± 6.1 
(n = 7)
85.1 ± 5.1 
(n = 8)
85.0 ± 5.3 
(n = 6)
90.1 ± 3.0 
(n = 7)
84.0 ± 5.2 
(n = 7)
Table 1. Effects of HFD consumption in in vivo fertilisation and in vitro embryo development. *No. of females 
with copulatory plug/total number of caged females.
Figure 3. Effects of HFD consumption in reproductive organs of B6CF1 male mice. (a) Mean weight of 
testicles (n = 8) and (b) epididymides (nNFD = 7, nHFD = 9). (c) Representative micrographs of Hematoxylin and 
Eosin stained testicular and caput epididymal sections. Bar = 50 µm. (d) Mean weight of gonadal fat (nNFD = 4, 
nHFD = 3). Data are expressed as mean ± SEM. **p < 0.01.
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Discussion
In the current study, we explored the impact of HFD-induced MetS-like condition on male fertility and sperm 
functionality of mice with high reproductive performance. HFD-fed B6CF1 animals developed a physiological 
condition compatible with MetS that included significant rises in body weight, fasting glucose and cholesterol 
levels, as well as glucose intolerance. Our primary finding is that this metabolic condition did not impact on the 
reproductive performance of hybrid B6CF1 animals, albeit a significant decrease in sperm count.
The fact that the HFD-challenged B6CF1 males were fertile is in accordance with the growing list of conflict-
ing data around the effects of MetS on male reproduction in rodents and humans10–15,17. This controversy is not 
surprising given that metabolic diseases are a combination of genetic and environmental factors, and its impact 
on fertility may be different between individuals. Among the factors that might confound the results are the com-
position and/or characteristics of the HFD used in each study with a direct consequence in the development of 
MetS. Moreover, it has been suggested that the effects of dietary fat on health and disease are likely to depend on 
the balance of other macro and micronutrients21,22. In this sense, we found some differences in body weight gain 
Figure 4. Effects of HFD consumption in sperm parameters of B6CF1 male mice. (a) Sperm count, (b) sperm 
viability, (c) percentage of abnormal sperm and (d) progressive motility in NFD- and HFD-fed mice (nNFD = 9, 
nHFD = 9). Data are expressed as mean ± SEM. *p < 0.05.
Figure 5. Effects of HFD consumption in sperm fertilising ability of B6CF1 male mice. (a) Percentage 
of acrosome reaction before (fresh) and after capacitation (capacitated) (nNFD = 7, nHFD = 7), (b) in vitro 
fertilisation rate (nNFD = 8, nHFD = 8) and (c) in vitro embryo development rate (nNFD = 6, nHFD = 6) from NFD- 
and HFD-fed mice. Data are expressed as mean ± SEM.
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and food consumption between our study, using a prepared diet, and others using commercial ones. Interestingly, 
whereas in our experimental conditions the significant difference in body weight between the two groups was 
reached after 11 weeks of treatment, other studies achieved weight differences before 6 weeks of high-fat feed-
ing23–28. This delay in reaching differences in body weight might be due to the reduced food intake of HFD-fed 
mice in our study with a consequent energy intake only 12% higher than NFD controls, in contrast to the 55% and 
20% increases reported by others26,27. In addition, examination of the livers showed that the HFD treatment did 
not produce steatosis or increases in the organ size in B6CF1 males as observed in other mouse models23,25,29,30, 
that could be a consequence of the aforementioned gradual intake of excessive fat. In this regard, considering that 
gut microbiota has emerged recently as being crucial in the etiology of metabolic diseases (reviewed in31), the 
possibility that in our study the MetS-like condition was attenuated by the local microbiota cannot be ruled out.
Considering the multifactorial nature of MetS, the use of different mouse strains could contribute to a better 
understanding of the association between the metabolic disorder and fertility. Differently to the well-established 
C57BL/6 mouse model of HDF-induced MetS17,27,32, the B6CF1 strain has not been studied before and may 
exhibit a different susceptibility to HFD with different consequences on the reproductive phenotype. The fact that 
nowadays metabolic diseases are observed from an early age and could result in possible reproductive deficien-
cies in the future drives the development of new experimental models that better reflect the human situation. In 
this sense, the power of using the B6CF1 model relies on the hybrid vigor of the animals, with high number of 
pups per litter and good sperm quality, making this model more suitable than C57BL/6 to mimic diet-induced 
MetS in young men. In addition, the lack of preexisting fertility deficiencies in these B6CF1 animals allowed us to 
study the actual impact of MetS on fertility. Our results showed that the high reproductive performance of B6CF1 
males was not affected by HDF-induced MetS. Neither mating success, an indirect indicator of testosterone levels, 
nor in vivo sperm fertilising ability was changed after the HFD challenge, arguing against a robust causal effect 
of high-fat feeding on male infertility. In addition, in vitro early embryo development was not impaired in our 
model, although the possibility of paternal epigenetic inheritance of metabolic disorders due to HFD-induced 
paternal obesity (reviewed in33) requires further investigation. Altogether, the observed lack of fertility phenotype 
could be a consequence of the intrinsic reproductive potential of the B6CF1 animals and/or the gradual acquisi-
tion of MetS in our model. Therefore, the way in which the metabolic disorder develops in each individual could 
be one of the causes of the variability reported for the association between metabolic and fertility disorders in 
men.
HFD-fed males exhibited a higher amount of gonadal fat, proposed to increase testicular and epididymal 
temperature, thus affecting sperm production, maturation and storage34. In this sense, we observed a reduction in 
sperm count, similar to previous reports28,35,36 and opposed to others23,26,37,38. In addition, differently from other 
studies reporting deleterious effects of HFD on testicular morphological structure25,28–30,35,36, our histological 
analysis showed no major differences in this feature between groups, resulting in normal spermatogenesis and 
sperm morphology in the HFD group. However, HFD-fed mice exhibited a decrease in epididymal weight, con-
sistent with the lower epididymal sperm count. Although these reductions could be due to a decrease in testoster-
one levels, normal testis histology, copulatory behaviour and fertility in HFD-fed mice set aside a negative effect 
of this hormone on our model. Despite the fact that the most reported alteration in sperm from HFD-fed males 
turns out to be the decrease in motility23–25,37–40, we did not observe this deficiency in our animals. In the case of 
the mouse, as mentioned above, reports in the literature were principally performed in C57BL/6 background, 
different to the hybrid B6CF1 used here. In the overall, among all the analysed sperm parameters, only epididy-
mal sperm concentration was reduced in B6CF1 animals. However, it did not produce any impact on fertility, in 
accordance with previous results in another mouse model of sperm count reduction by unilateral vasectomy20. If 
this data could be extrapolated to humans in which sperm concentration remains a cornerstone of male fertility 
evaluation2, additional sperm functional tests should be considered as better prognostic indicators.
In summary, although HFD feeding altered some reproductive parameters, it did not compromise male fer-
tility in mice without preexisting reproductive deficiencies. Our findings suggest the possibility that fertility 
impairment in humans could be the result of a combination of different environmental and genetic factors that 
may act in a cumulative manner with other predisposing factors from any of the two members of the couple. It is 
important to mention that patients who consult for infertility, in general, are not evaluated in terms of their met-
abolic status. Therefore, the study of the metabolic status of each individual could offer an alternative treatment 
to assisted reproductive techniques (ART), for example through personalised nutrition, rendering reproductive 
benefits.
Methods
ethical approval. Approval for the study protocol was obtained from the Institutional Animal Care and 
Use Committee of Instituto de Biología y Medicina Experimental (No. 22/2017). Experiments involving animals 
were performed in accordance with the Guide for Care and Use of Laboratory Animals published by the National 
Institutes of Health.
Animals and reagents. Hybrid (C57BL/6xBALB/c)F1 (B6CF1) mice were housed in the animal facil-
ity at IBYME-CONICET (Buenos Aires, Argentina) and maintained with food and water ad libitum in a 
temperature-controlled room (23 °C) with light:dark (12:12 h, lights on: 7:00 AM) cycle. All reagents and chem-
icals were of molecular biology grade and were purchased from Sigma-Aldrich Chemicals (St Louis, MO, USA), 
unless otherwise specified.
Generation of a murine model of MetS-like condition. Three-week-old male mice (body weight: 
13 ± 2 g) were individually caged and randomly allocated to receive a control normal-fat diet (NFD, n = 9) or 
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a high-fat diet (HFD, n = 9) for 19 weeks. NFD consisted of regular chow food containing (in weight) 6.0% fat, 
24.0% protein and 40.5% carbohydrate (3210 kcal/kg) (GEPSA, Buenos Aires, Argentina). HFD was prepared 
by supplementation of NFD with lard (Hebos SA, Buenos Aires, Argentina) as previously described41, resulting 
in 30.3% fat, 17.8% protein and 30.0% carbohydrate (4640 kcal/kg). The composition of these macronutrients in 
the prepared HFD is comparable to that reported by others in fertility studies23,25,42. Body and food weights were 
recorded weekly.
Measurement of metabolic parameters. Fasting blood glucose levels were determined in a sample col-
lected from the tail vein after 6 h of fasting using a glucometer (Accu-chek active, Roche, Argentina). At the 
moment of euthanasia, blood was drawn by direct heart puncture, and serum was separated to measure cho-
lesterol and triglycerides levels with specific kits (Colestat enzimático and TG-Color, respectively; Wiener lab, 
Rosario, Argentina).
Glucose tolerance test (Gtt). GTT was performed at week 18 after 6 h of fasting by intraperitoneal (i.p.) 
administration of 2 g/kg body weight glucose (40% w/v in saline solution). Glucose concentration was measured 
using a glucometer as described before at time points 0 (prior to glucose administration), 15, 30, 60, and 120 min.
In vivo fertilisation assays. In vivo fertilisation assays were performed as previously described43. Briefly, 
immature females were superovulated by an injection (i.p.) of equine chorionic gonadotropin (eCG; 5UI; 4 h 
before lights turn out; Syntex, Buenos Aires, Argentina), followed by the administration (i.p.) of human chorionic 
gonadotropin (hCG; 5UI; 6 h before lights turn out; Syntex) 46 h later. After hCG administration each female was 
caged with a NFD- or HFD-fed male for one night, and successful mating was confirmed by the presence of a cop-
ulatory plug the following morning (day 0). Eggs were then recovered from the oviducts and transferred to 50 µl 
drops of fresh KSOM medium at 37 °C in a 5% (v/v) CO2 atmosphere in air. The percentage of 2-cell embryos on 
day 1, as an indicator of fertilisation, and the percentage of embryos in blastocyst stage on day 4 were determined.
Sperm capacitation. Mouse spermatozoa were recovered by incising the cauda epididymides in 300 µl 
capacitation medium44 supplemented with 0.3% (w/v) bovine serum albumin (BSA) under paraffin oil (Ewe, 
Sanitas SA, Buenos Aires, Argentina) (“swim-out”). Aliquots of the suspension were added to 300 μl fresh 
medium previously placed in tissue culture dishes to give a final concentration of 5–10 × 106 cells/ml. Sperm 
suspensions were then incubated for 90 min under paraffin oil at 37 °C in an atmosphere of 5% (v/v) CO2 in air.
Sperm parameters determination. To evaluate morphology and motility, sperm suspensions were placed 
on pre-warmed slides and analyzed subjectively under a light microscope (400×). We considered progressive 
motile sperm those cells that moved in a forward direction. We did not include in this category those sperm 
that vibrated or rotated in the same place. For sperm count, after swim-out, sperm suspensions were diluted in 
water to prevent sperm movement, and the number of sperm heads was recorded by a standard method using a 
Neubauer Chamber under a light microscope (400×). Sperm viability was assessed by dye exclusion using 0.5% 
w/v Eosin Y (Sigma), and the percentage of spermatozoa that did not incorporate the dye (i.e. viable spermato-
zoa) was determined employing a light microscope (400×).
Histological analysis. Liver, testes and epididymides were dissected, weighed and fixed for at least 24 h by 
immersion in 4% formaldehyde in phosphate buffered saline (livers) or Bouin solution (testes and epididymides). 
Tissues were then processed for paraffin embedding and sectioning by routine methods. Samples were stained 
with Hematoxylin and Eosin using standardised protocols and examined by light microscopy (100× or 400×).
Acrosome reaction assays. The acrosomal status of capacitated sperm was evaluated by Coomassie 
Brilliant Blue staining as previously described45. At least 400 spermatozoa were evaluated in each treatment slide 
in a light microscope (400×) and the percentage of spermatozoa with a reacted acrosome was calculated.
egg collection and in vitro fertilisation (IVF) assays. In vitro fertilisation was performed as previ-
ously described46. Briefly, female mice were superovulated by an injection of eCG, followed by hCG 48 h later. 
Egg-cumulus complexes were collected from the oviducts 13–14 h after hCG administration and pooled. 
Cumulus-intact eggs were inseminated with capacitated spermatozoa (final concentration 1–5 × 105 sperma-
tozoa/ml) and gametes were co-incubated for 5 h at 37 °C in an atmosphere of 5% (v/v) CO2 in air. Eggs were 
then transferred to fresh capacitation medium and 15 h later the percentage of two-cell embryos was recorded. 
Embryos were then transferred to fresh KSOM medium to evaluate the development to blastocyst stage as 
described before.
Statistical analysis. Statistical analyses were performed with GraphPad Prism Software (San Diego, CA, 
USA). For percentage data, arcsine transformation was performed before submitting them to statistical analysis. 
Shapiro-Wilk normality test was conducted for each set of values and data was considered not normal at p < 0.10. 
Homoscedasticity was evaluated by F test and in all cases variances were not significantly different between 
groups (p > 0.05). Statistical significance of the data that followed a normal distribution was analyzed with 
Student´s t-test (for food and energy intake, feed efficiency, cholesterol and triglycerides levels, organs’ weights, 
sperm count, viability, morphology, motility, acrosome reaction, and fertilisation and embryo development rates) 
or two-way analysis of variance (ANOVA) (for body weight over time). In these cases, values were presented as 
mean ± standard error of the mean (SEM). In the case of not normal distributions, statistical significance was 
analyzed with Mann-Whitney U test (for glucose determinations), and values were presented as median with 
interquartile range. In all cases, significance was established at p < 0.05.
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